Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Decillis

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Analytical Biochemistry|January 15, 1982
A novel method for protein quantitation using a competitive binding assayR Best, E Howell, A Decillis, et al.
Journal of the National Cancer Institute|December 9, 1997
Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancerB Fisher, J Dignam, N Wolmark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18B Fisher, A Brown, E Mamounas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Effect of preoperative chemotherapy on the outcome of women with operable breast cancerB Fisher, J Bryant, N Wolmark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2023
Effect of preoperative chemotherapy on the outcome of women with operable breast cancerB Fisher, J Bryant, N Wolmark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22B Fisher, S Anderson, D L Wickerham, et al.
Journal of the National Cancer Institute|November 6, 1996
Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumorsB Fisher, J Dignam, J Bryant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Further evaluation of intensified and increased total dose of cyclophosphamide for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-25B Fisher, S Anderson, A DeCillis, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Analytical Biochemistry|January 15, 1982
A novel method for protein quantitation using a competitive binding assayR Best, E Howell, A Decillis, et al.
Journal of the National Cancer Institute|December 9, 1997
Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancerB Fisher, J Dignam, N Wolmark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18B Fisher, A Brown, E Mamounas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Effect of preoperative chemotherapy on the outcome of women with operable breast cancerB Fisher, J Bryant, N Wolmark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2023
Effect of preoperative chemotherapy on the outcome of women with operable breast cancerB Fisher, J Bryant, N Wolmark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22B Fisher, S Anderson, D L Wickerham, et al.
Journal of the National Cancer Institute|November 6, 1996
Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumorsB Fisher, J Dignam, J Bryant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Further evaluation of intensified and increased total dose of cyclophosphamide for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-25B Fisher, S Anderson, A DeCillis, et al.
Pageof 1